Susquehanna International Group, LLP Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $2.9 Million - $4.43 Million	-149,800 Reduced 75.35%	49,000 $948,000
Q2 2024 Aug 15, 2024	BUY	$21.87 - $28.24 $870,426 - $1.12 Million	39,800 Added 25.03%	198,800 $5.17 Million
Q1 2024 May 07, 2024	SELL	$27.21 - $39.48 $1.85 Million - $2.69 Million	-68,100 Reduced 29.99%	159,000 $4.55 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $2.5 Million - $3.66 Million	117,900 Added 107.97%	227,100 $6.95 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $1.56 Million - $2.15 Million	-59,600 Reduced 35.31%	109,200 $2.93 Million
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $1.74 Million - $2.87 Million	69,300 Added 69.65%	168,800 $6.02 Million
Q1 2023 May 16, 2023	SELL	$23.68 - $38.51 $1.91 Million - $3.1 Million	-80,600 Reduced 44.75%	99,500 $2.53 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $778,400 - $1.13 Million	27,800 Added 18.25%	180,100 $7.3 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $68,149 - $111,113	2,300 Added 1.53%	152,300 $5.03 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $1.46 Million - $2.65 Million	52,400 Added 53.69%	150,000 $5.28 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $11.5 Million - $20.3 Million	-290,700 Reduced 74.86%	97,600 $4.49 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $464,720 - $660,080	8,000 Added 2.1%	388,300 $25.7 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $2.83 Million - $4.11 Million	-48,400 Reduced 11.29%	380,300 $23.7 Million
Q2 2021 Aug 11, 2021	BUY	$62.15 - $90.32 $2.05 Million - $2.98 Million	33,000 Added 8.34%	428,700 $35.5 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $6.68 Million - $9.85 Million	-108,900 Reduced 21.58%	395,700 $26.2 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $1.47 Million - $2.87 Million	33,600 Added 7.13%	504,600 $38.7 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $86,346 - $133,302	-2,600 Reduced 0.55%	471,000 $20.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $4.42 Million - $7.32 Million	169,100 Added 55.53%	473,600 $20.5 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $4.69 Million - $14.4 Million	-228,300 Reduced 42.85%	304,500 $8.76 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $8.96 Million - $23.2 Million	318,400 Added 148.51%	532,800 $33.8 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $709,020 - $941,220	-27,000 Reduced 11.18%	214,400 $6.04 Million
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $1.82 Million - $3.01 Million	-104,600 Reduced 30.23%	241,400 $6.4 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $1.82 Million - $3.05 Million	151,000 Added 77.44%	346,000 $6.35 Million
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $3.18 Million - $5.84 Million	-296,200 Reduced 60.3%	195,000 $2.42 Million
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $2.21 Million - $3.21 Million	158,100 Added 47.46%	491,200 $9.42 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $1.17 Million - $2.59 Million	184,400 Added 124.01%	333,100 $4.53 Million
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $329,964 - $677,668	-88,700 Reduced 37.36%	148,700 $1.07 Million
Q4 2017 Feb 14, 2018	SELL	$3.14 - $4.5 $90,118 - $129,150	-28,700 Reduced 10.79%	237,400 $874,000
Q3 2017 Nov 14, 2017	BUY	$1.69 - $4.33 $449,709 - $1.15 Million	266,100	266,100 $1.15 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.97B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account